MedPath

Comparison of 2 Tests to Diagnose Cognitive Dysfunctions in Alcohol Disease

Completed
Conditions
Alcohol Use Disorder
Interventions
Other: MoCA (Montreal Cognitive Assessment) test
Other: BEARNI (Brief Evaluation of Alcohol Related Neuropsychological Impairment) Test
Registration Number
NCT04009707
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
Brief Summary

The objective of this study is therefore to compare the results obtained with these two screening tests, using as gold standard the results obtained by the battery of neuropsychological reference tests.

Detailed Description

Recently, a new screening test for cognitive disorders was specifically developed for patients with UAS: BEARNI (Brief Evaluation of Alcohol-Related Neuropsychological Impairments). Since the BEARNI is presented as the reference test, the investigators have systematically proposed it to hospitalized patients, in combination with the usual check-up. In practice, at admission, patients were therefore given two screening tests, the MoCA and the BEARNI. In the event of an anomaly in at least one of these tests, a battery of confirmatory neuropsychological tests was performed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • patients with alcoo use desorder
  • Patient cared for in the addictology department of the University Hospital of Nîmes
Exclusion Criteria
  • refusal to use the data

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
patients with alcool use desordersBEARNI (Brief Evaluation of Alcohol Related Neuropsychological Impairment) TestPatient cared for in the addictology department of the University Hospital of Nîmes
patients with alcool use desordersMoCA (Montreal Cognitive Assessment) testPatient cared for in the addictology department of the University Hospital of Nîmes
Primary Outcome Measures
NameTimeMethod
specificityDay 1 (only 1 time)

comparison of the specificity of the 2 tests against the gold standard

sensitivityDay 1 (only 1 time)

comparison of the sensitivity of the 2 tests against the gold standard

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU de Nîmes

🇫🇷

Nîmes, France

© Copyright 2025. All Rights Reserved by MedPath